Sage Journals: Discover world-class research

Free access

Research article

First published 2010-11

Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy

Chen-Hsiung Yeh, Adam Abdool, Jean-Marie Bruey

Cancer Biomarkers

Free access

Research article

First published 2010-4

A Non–ATP-Competitive Dual Inhibitor of JAK2 V617F and BCR-ABL T315I Kinases

Shashidhar S. Jatiani, Stephen C. Cosenza, M.V. Ramana Reddy [...]

Genes & Cancer

Open access

Review article

First published 2010

Management of Chronic Myeloid Leukemia with BCR/ABL Inhibitors: Current Status and Future Perspectives

Peter Valent

Clinical Medicine Insights: Therapeutics

Free access

Research article

First published 2009-3

Suppression of Vascular Endothelial Growth Factor (VEGF) Expression by Targeting the Bcr-Abl Oncogene and Protein Tyrosine Kinase Activity in Bcr-Abl-positive Leukaemia Cells

L Li, R Zhang, ZY Fang [...]

Journal of International Medical Research

Open access

Research article

First published 2025

The Prognostic Value of B12/CRP Ratio (BCR) in Patients Diagnosed With Solid Cancer

Merve Keskinkilic, Elif Cetin Basaran, Tugba Yavuzsen

Clinical Medicine Insights: Oncology

Free access

Research article

First published 2010-4

Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML)

Ajoy K. Samanta, Sandip N. Chakraborty, Yan Wang [...]

Genes & Cancer

Open access

Research article

First published 2017-12

Emodin Exerts an Antiapoptotic Effect on Human Chronic Myelocytic Leukemia K562 Cell Lines by Targeting the PTEN/PI3K-AKT Signaling Pathway and Deleting BCR-ABL

Chun-Guang Wang, Liang Zhong, Yong-Li Liu [...]

Integrative Cancer Therapies

Open access

Research article

First published 2017-6

Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells

Jia-Hua Zhang, Yan-Li He, Rui Zhu [...]

Tumor Biology

Open access

Review article

First published 2018-9

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

Sandra Cuellar, Michael Vozniak, Jill Rhodes [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021-8

Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project

Mohammad A. J. Abdulla, Prem Chandra, Susanna El Akiki [...]

Cancer Control

Search results